Showing posts with label Industry Outlook. Show all posts
Showing posts with label Industry Outlook. Show all posts

Why Drug Firms Simply Cannot Escape Stringent Pharmacovigilance Procedures?

The total value of the pharmacovigilance market was $6,724.2 million in 2021, and it will grow with a CAGR of 9.5% in the coming years, to further increase to $15,259.8 million by the year2030. This industrial growth is majorly credited to the increasing occurrence of toxicity and ADRs, surging apprehensions concerning high patient obedience to drug use and drug safety. Moreover, government and non-government administrations are progressively concentrating on drug safety and effectiveness.

Approximately 0.2–24% of the cases of hospitalization are because of ADRs out of which 3.7% of people succumb to deadly ADRs. The principal reasons include a number of prescribed drugs, an increased number of new drugs, an inadequate PV system for ADRs monitoring, and the absence of consciousness and acquaintance with ADRs. In India, the ADR reporting rate is less than 1% while globally it is 5% because of a lack of cognizance about PV and ADR monitoring amongst patients and healthcare providers. 

At the global level, North America was the region to generate the highest value in the pharmacovigilance market in 2021 as a result of the existence of advanced healthcare infrastructure, high healthcare outlay, and a growing amount of innovative drug research studies. On the other hand, APAC is expected will have the fastest growth, in excess of 10.6%, in the coming years, largely because of the improving infrastructure of healthcare, growing drug research, and increasing occurrence of enduring pain.

As stated by Congressional Budget Office report, only about 12% of the medications undergoing clinical trials are ultimately permitted for use by the FDA. Also, the normal R&D spending per new drug ranges somewhere between below $1 billion and in excess of $2 billion. These contain the costs of laboratory research as well as clinical trials for effective new drugs, along with the spending on drugs that do not go beyond the stage of laboratory development, come in clinical trials, but miss the mark or are withdrawn by the manufacturer for profit, or are not given approval by the FDA.

With the increase in cases of the side-effect of drugs, and the awareness of the people about drug safety is propelling the demand for pharmacovigilance, all over the world. 

Read complete report along with TOC - Pharmacovigilance Market Outlook


Share:

Increasing Elderly Population Call for More Spinal Treatments

In 2021, the interbody spine implants market was valued at $1,904.8 million and will reach $2,471.8 million by 2030, growing at a rate of about 3% during the forecast period. The major factors responsible for the development of the market are the improvements in the technologies of spine surgery, an increase in demand for devices for spinal fusion because of the surge in the incidence of spinal ailments, rapid acceptance of minimally invasive surgeries for the spine, and surge in the introduction of innovative bone-grafting products.

It is given that spinal issues are more common in elderly people than in adolescents or youngsters. A rapid growth in the elderly population all over the globe, and especially in the Asian subcontinent will add up to the demand for interbody spinal implants.  The elderly population of India will touch 194 million in the year 2031 from 138 million in 2021, a 41% increase will be experienced over the next ten years as per a report of the NSO

The volume of patients having from spine disorders is rising at a global level. For treating these conditions doctors need cutting-edge implants and technologies. Some of the key ailments treated with the use of spine implants include scoliosis, degenerative disc disease, spondylolisthesis, fracture, and kyphosis.  As per a study of the NLM, more than 266 million people have lumbar DSD every year. This enormous population having spine disorders intensifies the requirement for interbody spine implants.

The metal-based implants will have the highest demand of over 45% in the interbody spine implants market and will have the highest growth rate in the years to come. This has a lot to do with the high usage of metal-based implants in spine surgeries, because of their durability, suppleness, and robustness. Apart from that, these comprise metals like stainless steel, tantalum, and titanium. Asa per the AAOS, most spinal implants are made with a combination of titanium alloys, pure titanium, and stainless steel.


Share:

Unmanned Underwater Vehicles Market To Boom During 2021–2030

The surging defense expenditure of countries and burgeoning demand for seafloor mapping data will drive the unmanned underwater vehicles market growth during the forecast period (2021–2030). According to P&S Intelligence, the market generated a revenue of $4,104.2 million in 2020. Moreover, the rising advancements in underwater inspection techniques and soaring demand for maritime security will facilitate the market growth in the foreseeable future. Currently, the market players are undertaking several creative approaches to augment the effectiveness of UUVs.

Unmanned Underwater Vehicles Market Outlook


The mounting defense expenditure is one of the primary growth drivers for the market. UUVs play an important role in naval warfare as they provide significant clandestine and standoff capabilities and can intelligently adapt to the changes in tactical situations. The onboard systems of UUVs can adapt to the mission plan and identify changes without requiring human assistance. Owing to the benefits offered by UUVs, the navy and other departments of defense of various countries are partnering with private companies to conduct research and development (R&D) for developing next-generation UUVs.

At present, the UUVs market is consolidated in nature, with the presence of few players such as Teledyne Technologies Inc., Lockheed Martin Corporation, Subsea 7 S.A., Saab AB, Oceanserver Technology Inc., Kongsberg Gruppen, Oceaneering International Inc., The Boeing Company, and Fugro. These market players are entering into partnerships to gain a competitive edge. For instance, in December 2019, Saab AB won a contract from the Swedish Defence Materiel Administration (FMV) for the development of a new self-propelled naval mine, which is based on autonomous underwater vehicle technology.

Thus, the growing defense budgets and escalating focus on maritime security will support the market growth during the forecast period.

Share:

Popular Posts